RNA Outsourcing Solutions
-
Accelerate Development With Large-Scale mRNA And LNP Production
10/16/2024
Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.
-
CDMO Services: Customized mRNA-LNP Solutions
11/11/2024
Take advantage of a highly connected CDMO network that has the capabilities to ensure quality, speed, scalability, and flexibility. Learn more about the services available.
-
Biologics Manufacturing
5/15/2024
ReciBioPharm GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.
-
Help Your Program Thrive With inSeption Group
6/13/2024
Experience the difference that dedicated, top-tier professionals can make in achieving excellence and innovative solutions in clinical outsourcing.
-
Services For Advancing mRNA-LNPs From Bench To Clinic
2/27/2023
Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.
-
RNA Therapies
5/15/2024
One Team, One Roof, One CDMO
ReciBioPharm’s expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.
-
Cell Therapy Product Characterization Services
Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.
-
CTDMO Services To Fast-Track The Advancement Of mRNA-Based Drugs
3/13/2024
Discover CTDMO services that establish robust, integrated, and consistent processes across all stages, enabling you to fast-track the advancement of your mRNA-based vaccines and therapeutics.